ConductScience.org, home

Paper26328536

Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.

El-Laboudi AH and 1 other. Diabetes Ther, 2015. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices. Papers, record 26328536. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26328536

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.
PubMed
Journal
Diabetes Ther
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El-Laboudi AHAhmed H
2Oliver NNick

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
II-LA-0313-20004Department of HealthUnited KingdomPubMed
MC_PC_12015Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120693354Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.Diabetes Care2010https://conductscience.org/library/papers/20693354PubMed
218671795Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis.Diabetes Obes Metab2009https://conductscience.org/library/papers/18671795PubMed
324392996The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.Curr Med Res Opin2014https://conductscience.org/library/papers/24392996PubMed
49892228Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.Diabetes1999https://conductscience.org/library/papers/9892228PubMed
525352633Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data.J Diabetes Sci Technol2015https://conductscience.org/library/papers/25352633PubMed
624367934Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Diabetes Technol Ther2014https://conductscience.org/library/papers/24367934PubMed
722920797Ultrafast-acting insulins: state of the art.J Diabetes Sci Technol2012https://conductscience.org/library/papers/22920797PubMed
824089542Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.Diabetes Care2013https://conductscience.org/library/papers/24089542PubMed
925113814Effect of local heating on postprandial blood glucose excursions using the InsuPad device: results of an outpatient crossover study.J Diabetes Sci Technol2014https://conductscience.org/library/papers/25113814PubMed
107000239Sauna-induced acceleration in insulin absorption from subcutaneous injection site.Br Med J1980https://conductscience.org/library/papers/7000239PubMed
1125565442How to overcome the limitations of current insulin administration with new non-invasive delivery systems.Ther Deliv2015https://conductscience.org/library/papers/25565442PubMed
1224610683Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device.Diabetes Metab Res Rev2014https://conductscience.org/library/papers/24610683PubMed
1326037035Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.Drug Deliv Transl Res2015https://conductscience.org/library/papers/26037035PubMed
1424940825Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control.Curr Med Res Opin2014https://conductscience.org/library/papers/24940825PubMed
1525846340Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.Diabetes Obes Metab2015https://conductscience.org/library/papers/25846340PubMed
1619539098
Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Clin Ther2009https://conductscience.org/library/papers/19539098PubMed
1712832307Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.Diabetes Care2003https://conductscience.org/library/papers/12832307PubMed
1821715522Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.Diabetes Care2011https://conductscience.org/library/papers/21715522PubMed
1920618882How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes.Int J Clin Pract2010https://conductscience.org/library/papers/20618882PubMed
2023107353Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.Pediatr Diabetes2013https://conductscience.org/library/papers/23107353PubMed

See all 41 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40718205The 'Designer' Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology?Cureus2025https://conductscience.org/library/papers/40718205PubMed
36213069Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36213069PubMed
28755444Bolusing frequency and amount impacts glucose control during hybrid closed-loop.Diabet Med2018https://conductscience.org/library/papers/28755444PubMed
27364997Coming of age: the artificial pancreas for type 1 diabetes.Diabetologia2016https://conductscience.org/library/papers/27364997PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26328536

GET https://conductscience.org/api/papers/v1/26328536/references?page=2